Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bydureon (Exenatide) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Bydureon side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: female, weighing 90.7 kg (199.5 pounds)
Reactions: Weight Decreased, Visual Acuity Reduced, Blood Glucose Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bydureon
Other drugs received by patient: Metformin Hydrochloride; Actos; Glipizide
|